AB
TYRA icon

Amalgamated Bank’s Tyra Biosciences TYRA Stock Holding History

Amalgamated Bank’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-814
Closed -$21K – 2744
2025
Q4 		$21K Buy
814
+113
+16% +$2.08K ﹤0.01% 2099
2025
Q3 		$10K Hold
701
– – ﹤0.01% 2486
2025
Q2 		$7K Hold
701
– – ﹤0.01% 2607
2025
Q1 		$7K Buy
701
+277
+65% +$3.58K ﹤0.01% 2551
2024
Q4 		$6K Hold
424
– – ﹤0.01% 2688
2024
Q3 		$10K Hold
424
– – ﹤0.01% 2478
2024
Q2 		$7K Hold
424
– – ﹤0.01% 2647
2024
Q1 		$7K Sell
424
-1,021
-71% -$16.7K ﹤0.01% 2612
2023
Q4 		$20K Sell
1,445
-126
-8% -$1.63K ﹤0.01% 2656
2023
Q3 		$22K Hold
1,571
– – ﹤0.01% 2619
2023
Q2 		$27K Buy
1,571
+246
+19% +$3.57K ﹤0.01% 2596
2023
Q1 		$21K Sell
1,325
-296
-18% -$3.52K ﹤0.01% 2634
2022
Q4 		$12K Hold
1,621
– – ﹤0.01% 2859
2022
Q3 		$14K Hold
1,621
– – ﹤0.01% 2896
2022
Q2 		$12K Sell
1,621
-150
-8% -$1.19K ﹤0.01% 2968
2022
Q1 		$19K Buy
+1,771
New +$21K ﹤0.01% 2824

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
APMC
Alta Partners Management Company Jackson, Wyoming $151M AUM 296.21% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Amalgamated Bank's TYRA Position: Q1 2026 in Review

Amalgamated Bank sold out of Tyra Biosciences (TYRA) in Q1 2026, closing a stake of 814 shares — an estimated $21K sold.

Amalgamated Bank first reported a position in TYRA in Q1 2022 and held it in 16 quarters. The position peaked at $27K in Q2 2023. 164 funds tracked by Wall St. Rank hold TYRA as of Q1 2026.

  • Amalgamated Bank reported no remaining Tyra Biosciences position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 814 Tyra Biosciences shares in Q1 2026, an estimated $21K.
  • Amalgamated Bank first reported a position in Tyra Biosciences in Q1 2022 and held it in 16 quarters.
  • Amalgamated Bank's Tyra Biosciences position peaked at $27K in Q2 2023.
  • 164 funds tracked by Wall St. Rank held Tyra Biosciences as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.